Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17428524 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Enrolling by invitation Effects of USP Methylene Blue on Cognitive and fMRI Brain Activity
Condition: Brain Activity
Interventions: Drug: Methylene Blue (USP grade, 280mg oral);   Drug: Placebo

Indicates status has not been verified in more than two years